Chen, Yuehong
Liu, Feng
Chen, Xinhua
Li, Wenyi
Li, Kejun
Cai, Hailang
Wang, Shunyi
Wang, Honglei
Xu, Ke
Zhang, Chenxi
Ye, Shengzhi
Shen, Yunhao
Mou, Tingyu
Cai, Shumin
Zhou, Jianwei
Yu, Jiang
Funding for this research was provided by:
Guangdong Provincial Key Labaratory of Precision Medicine for Gastrointestinal Cancer (2020B121201004)
Natural Science Foundation Regional Joint Fund of Guangdong Province, China (2020A1515110140)
Medical Scientific Research Foundation of Guangdong Province, China (A2021444)
Natural Science Foundation of Guangdong Province of China (2023A1515010276)
the Key Research and Development Program of Hebei (19227128D)
the President Fund of Nanfang Hospital (2021B003)
Article History
Received: 3 August 2023
Accepted: 15 December 2023
First Online: 2 January 2024
Declarations
:
: This study was approved by Southern Medical University. The study protocols concerning human subjects are consistent with the principles of the Declaration of Helsinki and approved by the Ethics Committee of Nanfang Hospital. Written informed consent was obtained from the patients at Nanfang hospital. Animal related research protocols are consistent with ARRIVE guidelines (ExternalRef removed), and were approved by the Ethics Committee on Use and Care of Animals, Southern Medical University.
: Not applicable.
: The authors declare no competing interests.